STOCK TITAN

Century Therapeutics officer plans 534-share sale

An officer of Century Therapeutics filed a Rule 144 notice to sell 534 IPSC shares, partly to cover taxes from a vested equity award.

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Century Therapeutics, Inc. (IPSC) has a notice of proposed sale of common stock under Rule 144 by officer Gregory Russotti. The notice covers the planned sale of 534 shares of common stock through Fidelity Brokerage Services LLC on NASDAQ. The filer also reports prior sales in the last three months, and notes that the transaction includes shares sold to satisfy a tax obligation arising from the settlement of a vested equity award.

Positive

  • None.

Negative

  • None.
Shares proposed to be sold 534 shares Rule 144 sale of Century Therapeutics, Inc. common stock
Aggregate market value of proposed sale $1,094.43 Value listed for 534 IPSC shares in the Rule 144 notice
Shares sold June 8, 2026 524 shares Prior IPSC common stock sale reported in last three months
Proceeds June 8, 2026 sale $1,106.01 Aggregate amount for 524 IPSC shares sold June 8, 2026
Shares sold June 12, 2026 2,584 shares Second IPSC common stock sale reported in last three months
Proceeds June 12, 2026 sale $5,767.75 Aggregate amount for 2,584 IPSC shares sold June 12, 2026
Date of Rule 144 notice September 8, 2026 Date the Form 144 notice was filed
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Stock Vesting financial
"Common | 09/04/2026 | Restricted Stock Vesting | Issuer"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
vested equity award financial
"resulting from the settlement of a vested equity award distribution"
attorney-in-fact regulatory
"as attorney-in-fact for Gregory Russotti"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

What insider transaction did IPSC disclose in this Form 144 filing?

The filing reports a proposed Rule 144 sale by officer Gregory Russotti of 534 shares of Century Therapeutics, Inc. common stock through Fidelity Brokerage Services LLC on NASDAQ, with part of the sale intended to cover taxes from a vested equity award.

How many IPSC shares are proposed to be sold under this Rule 144 notice?

The notice covers a proposed sale of 534 shares of Century Therapeutics, Inc. common stock. These shares are to be sold through Fidelity Brokerage Services LLC, with the sale reported under Rule 144 for resales of restricted or control securities.

What is the stated value of the IPSC shares in the proposed Rule 144 sale?

The Form 144 lists an aggregate market value of $1,094.43 for the 534 shares of Century Therapeutics, Inc. common stock proposed to be sold through Fidelity Brokerage Services LLC on NASDAQ.

What prior IPSC share sales by Gregory Russotti are reported in the last three months?

The filing reports that Gregory Russotti sold 524 shares of IPSC common stock on June 8, 2026 for $1,106.01 and 2,584 shares on June 12, 2026 for $5,767.75 over the preceding three months.

Why does the IPSC Form 144 say some shares are being sold?

The remarks state that the sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution, indicating part of the transaction is to satisfy related tax liabilities.

Who is executing the proposed IPSC share sale on behalf of the officer?

The notice is signed by Jennifer Ruchti as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for officer Gregory Russotti in connection with the Rule 144 sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading